Raymond James Financial’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.64M Buy
484,157
+10,171
+2% +$240K ﹤0.01% 2058
2025
Q4
$15.5M Sell
473,986
-67,425
-12% -$2.89M ﹤0.01% 1617
2025
Q3
$30.7M Buy
541,411
+87,412
+19% +$4.48M 0.01% 1123
2025
Q2
$22.6M Sell
453,999
-97,121
-18% -$4.39M 0.01% 1266
2025
Q1
$16.3M Sell
551,120
-195,286
-26% -$7.25M 0.01% 1465
2024
Q4
$18M Buy
+746,406
New +$18.5M 0.01% 1406

Other funds holding HIMS

Raymond James Financial's HIMS Position: Q1 2026 in Review

Raymond James Financial increased its Hims & Hers Health (HIMS) stake by 2.1% in Q1 2026, buying an estimated $240K and bringing the position to 484,157 shares worth $9.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Raymond James Financial first reported a position in HIMS in Q4 2024 and has held it in 6 quarters since. The position peaked at $30.7M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Raymond James Financial held 484,157 shares of Hims & Hers Health worth $9.64M as of Q1 2026.
  • Raymond James Financial bought 10,171 Hims & Hers Health shares in Q1 2026, an estimated $240K.
  • Hims & Hers Health made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2058 holding.
  • Raymond James Financial first reported a position in Hims & Hers Health in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Hims & Hers Health position peaked at $30.7M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.